Evidence map›Paper›PMID 38149847›Full record

ArticleeLife2023

Vertical transmission of maternal DNA through extracellular vesicles associates with altered embryo bioenergetics during the periconception period.

David Bolumar, Javier Moncayo-Arlandi, Javier Gonzalez-Fernandez, Ana Ochando, Inmaculada Moreno, Ana Monteagudo-Sanchez, Carlos Marin, Antonio Diez, Paula Fabra, Miguel Angel Checa and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

David Bolumar *Igenomix Foundation, INCLIVA Health Research Institute, Valencia, Spain.ORCID 0000-0002-6234-3821
Javier Moncayo-Arlandi *Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Javier Gonzalez-FernandezCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Ana OchandoCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Inmaculada MorenoCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Ana Monteagudo-SanchezCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Carlos MarinIgenomix Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Antonio DiezIgenomix Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Paula FabraClinica Fertty, Barcelona, Spain.
Miguel Angel ChecaClinica Fertty, Barcelona, Spain.
Juan Jose EspinosClinica Fertty, Barcelona, Spain.
David K GardnerSchool of Biosciences, University of Melbourne, Parkville, Australia.ORCID 0000-0003-3138-8274
Carlos SimonCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Felipe VilellaCarlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.ORCID 0000-0002-0039-9846
INCLIVA Health Research Institute · ESHarvard University · USThe University of Melbourne · AUUniversitat Pompeu Fabra · ES

Funding

Instituto de Salud Carlos III CPII18/00020Instituto de Salud Carlos III FI19/00159Instituto de Salud Carlos III PI18/00957Instituto de Salud Carlos III PI21/00235Instituto de Salud Carlos III PI21/00528Ministerio de Educación, Cultura y Deporte FPU15/02248
6 · The paper itself

Abstract

The transmission of DNA through extracellular vesicles (EVs) represents a novel genetic material transfer mechanism that may impact genome evolution and tumorigenesis. We aimed to investigate the potential for vertical DNA transmission within maternal endometrial EVs to the pre-implantation embryo and describe any effect on embryo bioenergetics. We discovered that the human endometrium secretes all three general subtypes of EV - apoptotic bodies (ABs), microvesicles (MVs), and exosomes (EXOs) - into the human endometrial fluid (EF) within the uterine cavity. EVs become uniformly secreted into the EF during the menstrual cycle, with the proportion of different EV populations remaining constant; however, MVs contain significantly higher levels of mitochondrial (mt)DNA than ABs or EXOs. During the window of implantation, MVs contain an eleven-fold higher level of mtDNA when compared to cells-of-origin within the receptive endometrium, which possesses a lower mtDNA content and displays the upregulated expression of mitophagy-related genes. Furthermore, we demonstrate the internalization of EV-derived nuclear-encoded (n)DNA/mtDNA by trophoblast cells of murine embryos, which associates with a reduction in mitochondrial respiration and ATP production. These findings suggest that the maternal endometrium suffers a reduction in mtDNA content during the preconceptional period, that nDNA/mtDNA become packaged into secreted EVs that the embryo uptakes, and that the transfer of DNA to the embryo within EVs occurs alongside the modulation of bioenergetics during implantation.

Indexed as

ExosomesExtracellular VesiclesAnimalsDNA, MitochondrialEmbryo ImplantationEmbryo, MammalianFemaleHumansMiceDNA, Mitochondrialdevelopmental biologyendometriumexosomesextracellular vesicleshumanmaternal-embryonic crosstalkmedicinemetabolismmitochondrial DNAmouse

Identifiers

PMID38149847
PMCPMC10752591
OpenAlexW4381738926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.